Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial

Background Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosi...

Full description

Bibliographic Details
Main Authors: Farzad Allameh, Hamidreza Qashqai, Hamzeh Mazaherylaghab, Jalil Hosseini
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2019-10-01
Series:International Journal of Fertility and Sterility
Subjects:
Online Access:http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdf
id doaj-4cb7a5eae27f4c8b99d7af5ab704fe2f
record_format Article
spelling doaj-4cb7a5eae27f4c8b99d7af5ab704fe2f2020-11-25T04:10:40ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782019-10-0113324024410.22074/ijfs.2019.566445554Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical TrialFarzad Allameh0Hamidreza Qashqai1Hamzeh Mazaherylaghab2Jalil Hosseini3Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranUrology Department, Imam Sajjad Hospital, Iran University of Medical Sciences, Shahriar, Iran4Faculty of Medicine, Hamedan University of Medical Sciences, Hamedan, IranMen's Health and Reproductive Health Research Center (MHRHRC), Reconstructive Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranBackground Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosis and stricture. Materials and Methods In this randomized clinical trial, 44 patients were assigned to two groups randomly during a one-year study and the data of 40 patients were analyzed. The patients were followed up for 6 months after surgery. The case group (n=19) was treated by vasovasostomy with intra-operative local MMC. The control group (n=21) underwent standard vasovasostomy. Results Mean sperm count in MMC group was significantly higher than the controls. The sperm count of more than 20 million/ml was respectively 53% and 14% in MMC and control groups. In a subgroup where the interval between vasectomy and reversal was 5-10 years, post-reversal azoospermia was absent in MMC group, but 50% of the controls were still azoospermic. In addition, 80% of MMC group had more than 20 million/ml sperms, but all of the controls had less than 20 million/ml sperms. No significant complication was seen. Conclusion Intra-operative local MMC in vasovasostomy can be regarded as a safe and efficient technique which has several advantages including lower cost. Increase of sperm count is the main effect of local MMC applica- tion that is more prominent when the interval between vasectomy and reversal is 5-10 years (Registration number: IRCT2015092324166N1).http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdfclinical trialmitomycin csperm countvasectomy reversalvasovasostomy
collection DOAJ
language English
format Article
sources DOAJ
author Farzad Allameh
Hamidreza Qashqai
Hamzeh Mazaherylaghab
Jalil Hosseini
spellingShingle Farzad Allameh
Hamidreza Qashqai
Hamzeh Mazaherylaghab
Jalil Hosseini
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
International Journal of Fertility and Sterility
clinical trial
mitomycin c
sperm count
vasectomy reversal
vasovasostomy
author_facet Farzad Allameh
Hamidreza Qashqai
Hamzeh Mazaherylaghab
Jalil Hosseini
author_sort Farzad Allameh
title Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
title_short Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
title_full Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
title_fullStr Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
title_full_unstemmed Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
title_sort efficacy of intraoperative mitomycin-c in vasovasostomy procedure: a randomized clinical trial
publisher Royan Institute (ACECR), Tehran
series International Journal of Fertility and Sterility
issn 2008-076X
2008-0778
publishDate 2019-10-01
description Background Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosis and stricture. Materials and Methods In this randomized clinical trial, 44 patients were assigned to two groups randomly during a one-year study and the data of 40 patients were analyzed. The patients were followed up for 6 months after surgery. The case group (n=19) was treated by vasovasostomy with intra-operative local MMC. The control group (n=21) underwent standard vasovasostomy. Results Mean sperm count in MMC group was significantly higher than the controls. The sperm count of more than 20 million/ml was respectively 53% and 14% in MMC and control groups. In a subgroup where the interval between vasectomy and reversal was 5-10 years, post-reversal azoospermia was absent in MMC group, but 50% of the controls were still azoospermic. In addition, 80% of MMC group had more than 20 million/ml sperms, but all of the controls had less than 20 million/ml sperms. No significant complication was seen. Conclusion Intra-operative local MMC in vasovasostomy can be regarded as a safe and efficient technique which has several advantages including lower cost. Increase of sperm count is the main effect of local MMC applica- tion that is more prominent when the interval between vasectomy and reversal is 5-10 years (Registration number: IRCT2015092324166N1).
topic clinical trial
mitomycin c
sperm count
vasectomy reversal
vasovasostomy
url http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdf
work_keys_str_mv AT farzadallameh efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial
AT hamidrezaqashqai efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial
AT hamzehmazaherylaghab efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial
AT jalilhosseini efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial
_version_ 1724419732563558400